ProFound AI® for DBT

FDA, CE & Health Canada | Breast | DBT | Amplifier Partner

Amplifier Marketplace Radiology

Description of use

ProFound AI® for DBT is a concurrent-read, cancer detection and workflow solution that rapidly analyzes each DBT slice, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy. The software is intended to assist radiologists in identifying soft tissue densities and calcifications that may be confirmed or dismissed by the radiologist.

Built on the latest deep-learning AI technology, ProFound AI® assists radiologists in addressing key challenges of reading 2D and 3D mammography.

Impact on radiologist performance when reading DBT with vs without ProFound AI®:

  • 8.0% increase in sensitivity
  • 6.9% increase in specificity
  • 7.2% decrease in recall rate
  • 52.7% decrease in reading time

Regulatory Clearance:

  • FDA Cleared, CE Mark Approved, Health Canada Licensed

How is the application integrated?

  • Results displayed in IDS7: Yes
  • DICOM output: MG CAD SR, DICOM GSPS, DICOM SC
  • CAD findings as image overlay: Yes
  • Worklist integration: Yes

Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.

Contact us

Referring articles

The below are peer-reviewed articles that have been submitted by the AI vendor to serve as scientific validation of the application.

Other applications by this vendor

PowerLook® Density Assessment
FDA, CE & Health Canada | DBT & FFDM
PowerLook Density Assessment is a software application intended for use with 2D FFDM and 2D Synthetic mammography images. PowerLook Density Assessment provides a BI-RADS 5th Edition breast density category to aid health care professionals in the assessment of breast tissue composition. PowerLook Density Assessment produces adjunctive information. It is not a diagnostic aid.
ProFound AI® for 2D Mammography
CE & Health Canada | FFDM
ProFound AI® 2D is a computer-assisted detection and diagnosis Artificial Intelligence (AI) software device intended to be used by interpreting physicians while reading 2D mammography exams from compatible 2D mammography systems. The system detects soft tissue densities (masses, architectural distortions and asymmetries) and calcifications in mammography images. The detections and certainty of finding, and case scores assist interpreting physicians in identifying soft tissue densities and calcifications that may be confirmed or dismissed.
ProFound AI® Risk
CE | FFDM & DBT
The ProFound AI® Risk clinical decision support tool is intended to be used by physicians to estimate a woman’s risk of developing breast cancer within 2 years of a normal mammogram. The tool is designed to inform and support physicians in their decision making process of personalizing screening or follow-up testing.

Let’s talk

Are you interested in learning more? Please do not hesitate to get in touch with us at Sectra.

Contact us

The application content is provided by the respective AI vendors.